Extensive preclinical evaluation of an infliximab biosimilar candidate.
Velasco-Velázquez MA, Salinas-Jazmín N, Hisaki-Itaya E, Cobos-Puc L, Xolalpa W, González G, Tenorio-Calvo A, Piña-Lara N, Juárez-Bayardo LC, Flores-Ortiz LF, Medina-Rivero E, Pérez NO, Pérez-Tapia SM.
Velasco-Velázquez MA, et al.
Eur J Pharm Sci. 2017 May 1;102:35-45. doi: 10.1016/j.ejps.2017.01.038. Epub 2017 Feb 7.
Eur J Pharm Sci. 2017.
PMID: 28188909